logo
  • Home
  • Technology
  • Solutions
  • Our Story
  • News
  • Careers
  • Contact

What’s happening

The latest insights, news and our media presence

  • All
  • Press Release
  • In The Media
  • Insights
  • Blog
  • Media Room

April 2022

  • Press release - Embion commits to transparency and investing in the planet this Earth Day!

March 2022

  • Press release - Embion joins Global Prebiotic Association to drive gut health awareness

December 2020

  • Press release Strategic Cooperation ASAHI EMBION
  • Pressemitteilung strategische Partnerschaft ASAHI und EMBION

November 2020

  • EN_Embion announces formation of Science and Advisory Board

October 2020

  • EN_EMBION kicks-off Series A with ALCEA grant
  • DE_EMBION startet Series A Runde mit Förderung der Stiftung ALCEA
  • FR_EMBION lance serie A avec fonds de la fondation ALCEA

July 2020

  • EN_EMBION revolutionizes biomass upcyling July 2020
  • DE_EMBION revolutioniert Biomasse-Upcycling Juli 2020
  • FR_EMBION revolutionne la valorisation de biomasse juillet 2020
Read Our Story

Privacy Policy

FOLLOW US

Read how we are supporting the Covid-19 response

EMBION’s COVID-19 RESPONSE

JOINING THE SOLIDARITY THROUGH TECHNOLOGY

Accelerating supplements and vaccines.

In supporting research and development efforts for COVID-19, we provide access to our platform technology for targeted extraction of potent ingredients and rapid development of new antigens. We follow WHO and Swiss government recommendations for safe work environment. We apply work-from-home and rotational program on our ever-expanding research and development team.

© 2020 Embion Technologies S.A. All rights reserved

Privacy Preference Center

Privacy Preferences